@article{UBHD-68164118, author={Bashari, Muhammad Hasan and Malvestiti, Stefano and Fan, Fengjuan and Vallet, Sonia and J{\"a}ger, Dirk and Podar, Klaus}, title={Individualized breast cancer therapy using Mcl-1 inhibition based combination}, year={2016}, language={eng}, issn={1569-8041}, volume={27(2016}, note={Gesehen am 11.09.2017}, journal={Annals of oncology}, doi={10.1016/S0923-7534(21)00174-5}, } @article{UBHD-68569166, author={Bashari, Muhammad Hasan and Fan, Fengjuan and Vallet, Sonia and Sattler, Martin and Arn, Melissa and Luckner-Minden, Claudia and Schulze-Bergkamen, Henning and Z{\"o}rnig, Inka and Marmé, Frederik and Schneeweiss, Andreas and Cardone, Michael H. and Opferman, Joseph T. and J{\"a}ger, Dirk and Podar, Klaus}, title={Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia}, subtitle={therapeutic implications}, year={2016}, pages={1-15}, language={eng}, issn={1465-542X}, volume={18}, number={Artikel-ID 26}, note={Gesehen am 22.04.2020}, journal={Breast cancer research}, doi={10.1186/s13058-016-0686-4}, } @article{UBHD-68328316, author={Fan, Fengjuan and Bashari, Muhammad Hasan and Malvestiti, Stefano and Vallet, Sonia and Seckinger, Anja and Hose, Dirk and Ball, Claudia R. and Glimm, Hanno and Goldschmidt, Hartmut and J{\"a}ger, Dirk and Podar, Klaus}, title={The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment}, year={2017}, pages={1570-1581}, language={eng}, issn={1476-5551}, volume={31}, number={7}, note={Advance online publication, 16 December 2016 ; Gesehen am 14.11.2018}, journal={Leukemia}, doi={10.1038/leu.2016.358}, } @article{UBHD-67678153, author={Fan, Fengjuan and Bashari, Muhammad Hasan and Vallet, Sonia and Goldschmidt, Hartmut and Schulze-Bergkamen, Henning and J{\"a}ger, Dirk and Podar, Klaus}, title={Targeting Mcl-1 for multiple myeloma (MM) therapy}, subtitle={drug-induced generation of Mcl-1 fragment Mcl-1(128-350) triggers MM cell death via c-Jun upregulation}, year={2014}, pages={286-94}, language={eng}, issn={1872-7980}, volume={343}, number={2}, note={Gesehen am 24.09.2014}, journal={Cancer letters}, doi={10.1016/j.canlet.2013.09.042}, } @article{UBHD-68447433, author={Gr{\"u}llich, Carsten and Vallet, Sonia and Hecht, Christopher and Duensing, Stefan and Hadaschik, Boris and J{\"a}ger, Dirk and Hohenfellner, Markus and Pahernik, Sascha}, title={Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence}, year={2016}, pages={238.e9-238.e17}, language={eng}, issn={1873-2496}, volume={34}, number={5}, note={Available online 28 December 2015 ; Gesehen am 29.10.2019}, journal={Urologic oncology}, doi={10.1016/j.urolonc.2015.11.022}, } @article{UBHD-68124938, author={H{\"o}fner, Thomas and Vallet, Sonia and Hadaschik, Boris and Pahernik, Sascha and Duensing, Stefan and Hohenfellner, Markus and J{\"a}ger, Dirk and Gr{\"u}llich, Carsten}, title={Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer}, subtitle={efficacy and predictive parameters in a large single center cohort}, year={2015}, pages={833-839}, language={eng}, issn={1433-8726}, volume={33}, number={6}, note={Published online: 12 August 2014 ; Gesehen am 01.06.2017}, journal={World journal of urology}, doi={10.1007/s00345-014-1375-5}, } @article{UBHD-68244187, author={Rosenberger, Friederike and Wiskemann, Joachim and Vallet, Sonia and Haag, Georg Martin and Schembri, Emanuel and J{\"a}ger, Dirk and Gr{\"u}llich, Carsten}, title={Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy}, subtitle={a controlled feasibility trial}, year={2017}, pages={3655-3664}, language={eng}, issn={1433-7339}, volume={25}, number={12}, note={Gesehen am 18.04.2018}, journal={Supportive care in cancer}, doi={10.1007/s00520-017-3788-3}, } @article{UBHD-68087915, author={Schott, Sarah and Vallet, Sonia}, title={In vitro and in vivo toxicity of 5-FdU-alendronate}, subtitle={a novel cytotoxic bone-seeking duplex drug against bone metastasis}, year={2015}, pages={816-826}, language={eng}, issn={1573-0646}, volume={33}, number={4}, note={Gesehen am 22.02.2017}, journal={Investigational new drugs}, doi={10.1007/s10637-015-0253-3}, } @article{UBHD-68991856, author={Vallet, Sonia and Anderson, Kenneth C.}, title={CCR1 as a target for multiple myeloma}, year={2011}, pages={1037-1047}, language={eng}, issn={1744-7631}, volume={15}, number={9}, note={Gesehen am 01.12.2022}, journal={Expert opinion on therapeutic targets}, doi={10.1517/14728222.2011.586634}, } @article{UBHD-68126757, author={Vallet, Sonia and Pahernik, Sascha and Tosev, Georgi and Hadaschik, Boris and Duensing, Stefan and Sedlaczek, Oliver and Hohenfellner, Markus and J{\"a}ger, Dirk and Gr{\"u}llich, Carsten}, title={Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer}, subtitle={retrospective analysis from a large-volume cancer center}, year={2015}, pages={e145-e152}, language={eng}, issn={1938-0682}, volume={13}, number={3}, note={Published online: 30 December 2014 ; Gesehen am 08.06.2017}, journal={Clinical genitourinary cancer}, doi={10.1016/j.clgc.2014.12.012}, } @book{UBHD-67958835, author={Vallet, Sonia}, title={Induction of activin A with lenalidomide in multiple myeloma}, subtitle={preclinical rationale for combination with the activin A inhibitor ACE-011.}, address={Heidelberg}, year={2015}, pages={III, 41 Bl{\"a}tter}, language={eng}, school={Dissertation, Ruprecht-Karls-Universit{\"a}t Heidelberg, 2015}, library={UB [Signatur: 2016 U 343]}, } @article{UBHD-68880861, author={Vallet, Sonia and Podar, Klaus}, title={New insights, recent advances, and current challenges in the biological treatment of multiple myeloma}, year={2013}, pages={S35-S53}, language={eng}, issn={1744-7682}, volume={13}, number={sup1}, note={Gesehen am 21.02.2022}, journal={Expert opinion on biological therapy}, doi={10.1517/14712598.2013.807337}, } @article{UBHD-68991858, author={Vallet, Sonia and Pozzi, S. and Patel, K. and Vaghela, N. and Fulciniti, M. T. and Veiby, P. and Hideshima, T. and Santo, L. and Cirstea, D. and Scadden, D. T. and Anderson, K. C. and Raje, N.}, title={A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function}, year={2011}, pages={1174-1181}, language={eng}, issn={1476-5551}, volume={25}, number={7}, note={Gesehen am 01.12.2022}, journal={Leukemia}, doi={10.1038/leu.2011.43}, } @article{UBHD-68582180, author={Vallet, Sonia and Bashari, Muhammad Hasan and Fan, Fengjuan and Malvestiti, Stefano and Schneeweiss, Andreas and Wuchter, Patrick and J{\"a}ger, Dirk and Podar, Klaus}, title={Pre-osteoblasts stimulate migration of breast cancer cells via the HGF/MET pathway}, year={2016}, pages={18 S.}, language={eng}, issn={1932-6203}, volume={11(2016}, note={Gesehen am 29.05.2020}, journal={PLOS ONE}, doi={10.1371/journal.pone.0150507}, } @article{UBHD-68407504, author={Vallet, Sonia and Schneeweiss, Andreas and J{\"a}ger, Dirk and Podar, Klaus}, title={Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer}, year={2019}, pages={585-596}, language={eng}, issn={1573-7217}, volume={173}, number={3}, note={First Online: 29 October 2018 ; Gesehen am 11.07.2019}, journal={Breast cancer research and treatment}, doi={10.1007/s10549-018-5022-5}, } @article{UBHD-68240237, author={Vallet, Sonia and Witzens-Harig, Mathias and J{\"a}ger, Dirk and Podar, Klaus}, title={Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies}, year={2012}, pages={473-494}, language={eng}, issn={1744-7666}, volume={13}, number={4}, note={Gesehen am 06.04.2018}, journal={Expert opinion on pharmacotherapy}, doi={10.1517/14656566.2012.656091}, } @article{UBHD-68465652, author={Zsch{\"a}bitz, Stefanie and Vallet, Sonia and Hadaschik, Boris and Karcher, Andreas and Pahernik, Sascha and Spath, Cathleen and Duensing, Stefan and J{\"a}ger, Dirk and Hohenfellner, Markus and Gr{\"u}llich, Carsten}, title={Efficacy of cabazitaxel treatment in metastatic castration resistant prostate cancer in second and later lines}, subtitle={an experience from two german centers}, year={2017}, pages={507-512}, language={eng}, issn={1837-9664}, volume={8}, number={4}, note={Gesehen am 10.12.2019}, journal={Journal of cancer}, doi={10.7150/jca.17644}, }